Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transtion by registering with Grants.gov and NIH eRA Commons now. |
Pathogenesis and Treatment of Dyskinesias in Parkinson's Disease
Release Date: July 18, 2002
Announcement Number: PAS-02-129
Application Receipt Date:
October 1, 2002
February 1, 2003
June 1, 2003
October 1, 2003
February 1, 2004
June 1, 2004
October 1, 2004
February 1, 2005
June 1, 2005
Funding Contact: NINDS Funding
Program Area: Neurodegeneration
Brief Description:
With this Program Announcement, the National Institute of Neurological Disorders and Stroke (NINDS) invites research grant
applications (R01) that address the development and treatment of dopamine-induced dyskinesias, a major complication of current
pharmacotherapy of Parkinson's disease. The purpose of this initiative is to 1) support the study of the pathophysiologic
basis of dopamine-induced dyskinesias; and 2) support the study of non- dopaminergic pharmacologic agents for the treatment
of dopamine-induced dyskinesias.
Choose an option to view additional funding announcements |
New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives |